Docoh
Loading...

PRPO Precipio

Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide, as well as proprietary products that serve laboratories worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment such as the Yale School of Medicine, Harvard's Dana-Farber Cancer Institute, and the University of Pennsylvania, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care.

Company profile

Ticker
PRPO
Exchange
CEO
Paul Kinnon
Employees
Incorporated
Location
Fiscal year end
Former names
TRANSGENOMIC INC
SEC CIK
IRS number
911789357

PRPO stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

14 May 21
30 Jul 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Precipio earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 2.29M 2.29M 2.29M 2.29M 2.29M 2.29M
Cash burn (monthly) 123.33K (positive/no burn) 712.33K 828.33K 433.33K 595.42K
Cash used (since last report) 493.4K n/a 2.85M 3.31M 1.73M 2.38M
Cash remaining 1.79M n/a -563.71K -1.03M 552.44K -95.98K
Runway (months of cash) 14.5 n/a -0.8 -1.2 1.3 -0.2

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
1 Jun 21 Sabet Ahmed Zaki Common Stock Buy Aquire P No No 3.369 151 508.72 4,879
1 Jun 21 Danieli Ilan Common Stock Buy Aquire P No No 3.3713 755 2.55K 22,217
1 Mar 21 Danieli Ilan Common Stock Buy Aquire P No No 2.46 1,025 2.52K 21,462
1 Mar 21 Andrews Ronald Asbury Employee Stock Option Common Stock Grant Aquire A No No 2.6 5,171 13.44K 5.171
1 Mar 21 Andrews Ronald Asbury Employee Stock Option Common Stock Grant Aquire A No No 2.6 2,069 5.38K 2,069

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change

Financial report summary

?
Risks
  • We face risks related to health pandemics and other widespread outbreaks of contagious disease, including the novel coronavirus, COVID-19, which could significantly disrupt our operations and impact our financial results.
Management Discussion
  • Net Change in Cash. Cash increased by $1.8 million and $0.5 million during the years ended December 31, 2020 and 2019, respectively.
  • Cash Flows Used in Operating Activities. The cash flows used in operating activities of $7.4 million during the year ended December 31, 2020 included a net loss of $10.6 million, an increase in accounts receivable of $1.6 million, an increase in inventories and other assets of $0.2 million and a decrease in accounts payable and operating lease liabilities of $0.5 million. These were partially offset by an increase in accrued expenses and other liabilities of $0.7 million and non-cash adjustments of $4.8 million. The non-cash adjustments included $1.3 million for the change in provision for losses on doubtful accounts. We routinely provide a reserve for doubtful accounts as a result of having limited in-network payer contracts. Non-cash adjustments also included $1.2 million for loss on extinguishment of convertible notes, which resulted from a March 2020 amendment to certain Bridge Notes whereby, among other things, the floor price at which conversions may occur was amended from $2.25 to $0.40. See Note 6 – Convertible Notes for further discussion. The other non-cash adjustments to net loss of approximately $2.3 million include, among other things, depreciation and amortization, warrant revaluations and stock based compensation. The cash flows used in operating activities in the year ended December 31, 2019 included the net loss of $13.2 million, an increase in accounts receivable of $0.8 million, a decrease in accounts payable of $1.9 million and a decrease in operating lease liabilities of $0.2 million. These were partially offset by a decrease in other assets of $0.4 million and non-cash adjustments of $6.6 million.
  • Cash Flows Used In Investing Activities. Cash flows used in investing activities were $0.1 million for the years ended December 31, 2020 and 2019, respectively, resulting from purchases of property and equipment partially offset by proceeds from sales of fixed assets.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: acute, agent, Amazon, AML, ATM, biotech, California, consent, consulting, counsel, derecognition, derecognized, float, forgiven, headcount, hematologic, indemnification, Instruction, Korean, large, leukemia, lower, manufactured, met, minute, MPN, myeloid, myeloproliferative, National, neoplasm, NPI, pathologist, pathology, pharma, practitioner, proprietary, rapid, reclassified, routinely, settle, settled, size, South, staffed, staffing, statute, sublease, transitioned, transitioning, type, unissued, upfront, USA, variety, website, writing, yield
Removed: adhere, aggregated, alleging, alternative, analyst, approach, approval, approving, arrangement, assign, begun, beneficially, bid, bifurcated, Bloomberg, breach, bringing, Campbell, canceled, Carlo, center, cloud, commencing, committed, composite, compute, computed, computing, consecutive, contemplated, continued, corporate, Corporation, Court, coverage, Crede, cumulative, daily, deal, delisted, delisting, deny, depending, derivative, deter, directing, disclose, discount, dissolution, distributed, District, earlier, embedded, enable, equal, equitably, escrow, event, exceed, exclusively, exempt, existed, governance, Group, high, holder, host, hosting, house, implementation, incomplete, independent, indeterminate, individually, insufficient, involuntary, issuing, Jesse, lawsuit, lesser, letter, Leviston, licensed, limitation, liquidated, liquidation, listed, longer, lowest, maintaining, maximum, methodology, misleading, Monte, negatively, notifying, occurrence, occurring, October, omission, owing, pari, participated, passu, penalty, penny, preliminarily, prohibition, proxy, ratably, reassessed, recapitalization, redeem, redemption, reduced, referred, refusal, regain, regular, release, released, remeasured, removal, removed, reorganization, repayment, representing, requiring, residing, restatement, reversal, reverse, satisfy, secondary, Secretary, selected, shareholder, similarly, situated, software, split, stipulation, stockholder, stringent, suit, superior, thereon, thereunder, timing, unamortized, unchanged, unpaid, upside, utilize, voluntary, VWAP, whichever, wrote